Sort
23,748 grants matching “melanoma”
POLYVALENT VACCINE IN IL-2+GM-CSF LIPOSOMES FOR MELANOMA
$350,675New York University School Of Medicine · R01 · FY2004 · CA
Targeted Screen for Novel Chemical Modulators of Wnt/Beta-Cat Signaling Pathway.
$350,675Brian D Dynlacht · New York University School Of Medicine · R01 · FY2015 · CA
The role of GPSM3 in tumor-promoting emergency myelopoiesis
$350,581Bin Zhang · Northwestern University At Chicago · R01 · FY2019 · CA
Lymphatic Imaging
$350,531Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Special BD LSR Fortessa
$350,505Manish S Patankar · University Of Wisconsin-Madison · S10 · FY2014 · OD
Optical Mapping of Nonmelanoma Skin Cancers
$350,325Massachusetts General Hospital · R01 · FY2004 · EB
NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases
$350,078Yolonda L Colson · Brigham And Women'S Hospital · R01 · FY2011 · CA
P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy
$350,064Yong Lu · Methodist Hospital Research Institute · R37 · FY2024 · CA
Single Cell Genomics Core
$350,027Michael L Whitfield · Dartmouth College · P20 · FY2021 · GM
Wnt Signaling in Xenopus Embryonic Development
$350,001Sergei Y Sokol · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · HD
Novel microarrays for DNA genotyping in the presence of excess background DNA
$350,000Alfredo Andres Celedon · Scanogen, Inc. · R43 · FY2014 · HG
Endothelial plasticity in glioma vascularization and therapy resistance
$350,000Yi Fan · University Of Pennsylvania · R01 · FY2016 · NS
Dual Inhibition of Mitochondrial Matrix Chaperones and Anti-Apoptotic Bcl-2 Family Members for Glioblastoma Therapy.
$350,000Markus D Siegelin · Columbia University Health Sciences · R01 · FY2017 · NS
Dual Inhibition of Mitochondrial Matrix Chaperones and Anti-Apoptotic Bcl-2 Family Members for Glioblastoma Therapy.
$350,000Markus D Siegelin · Columbia University Health Sciences · R01 · FY2016 · NS
Dual Inhibition of Mitochondrial Matrix Chaperones and Anti-Apoptotic Bcl-2 Family Members for Glioblastoma Therapy.
$350,000Markus D Siegelin · Columbia University Health Sciences · R01 · FY2019 · NS
Modulated Imaging: A Wide-field Optical Imaging Platform for Clinical Research
$350,000David John Cuccia · Modulated Imaging, Inc. · R43 · FY2010 · RR
Novel microarrays for DNA genotyping in the presence of excess background DNA
$350,000Alfredo Andres Celedon · Scanogen, Inc. · R43 · FY2015 · HG
Endothelial plasticity in glioma vascularization and therapy resistance
$350,000Yi Fan · University Of Pennsylvania · R01 · FY2015 · NS
Modulated Imaging: A Wide-field Optical Imaging Platform for Clinical Research
$350,000David John Cuccia · Modulated Imaging, Inc. · R43 · FY2009 · RR
Dual Inhibition of Mitochondrial Matrix Chaperones and Anti-Apoptotic Bcl-2 Family Members for Glioblastoma Therapy.
$350,000Markus D Siegelin · Columbia University Health Sciences · R01 · FY2020 · NS
Endothelial plasticity in glioma vascularization and therapy resistance
$350,000Yi Fan · University Of Pennsylvania · R01 · FY2017 · NS
Endothelial plasticity in glioma vascularization and therapy resistance
$350,000Yi Fan · University Of Pennsylvania · R01 · FY2019 · NS
Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection
$349,988Michele Carbone · University Of Hawaii At Manoa · R01 · FY2015 · CA
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment
$349,981Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2022 · CA
Combining senescence-inducing and senolytic agents to improve melanoma therapy
$349,980Anna E Vilgelm · Ohio State University · R37 · FY2021 · CA